Use of Pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma

Clinica Chimica Acta

Volumn 342, Issue 1-2, 2004, Pages 137-143

  Zhang, Zhenzhong ^a,b   Liu, Wei ^a   Jia, Xin ^a   Gao, Yan ^a   Hemminki, Kari ^b   Lindholm, Bengt ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

BCC; Cyclin D1; Interleukin gene; MTHFR; SNPs

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYCLIN D1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER PATIENT; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LINKAGE GROUP; GENE SEQUENCE; GENOTYPE; HUMAN; MALE; POPULATION GENETICS; PRIORITY JOURNAL; PYROSEQUENCING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

ADULT; AGED; CARCINOMA, BASAL CELL; COHORT STUDIES; CYCLIN D1; DNA PRIMERS; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS;

EID: 1542394943     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.12.010     Document Type: Article

References (20)

1. Jee S.H., Shen S.C., Chiu H.C., Tsai W.L., Kuo M.L. Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency. Oncogene. 20(2):2001;198-208.
2. Yen H.T., Chiang L.C., Wen K.H., Tsai C.C., Yu C.L., Yu H.S. The expression of cytokines by an established basal cell carcinoma cell line (BCC-1/KMC) compared with cultured normal keratinocytes. Arch. Dermatol. Res. 288(3):1996;157-161.
3. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer. 92(6 Suppl.):2001;1684-1688.
4. Izzo J.G., Papadimitrakopoulou V.A., Liu D.D., den Hollander P.L., Babenko I.M., Keck J.et al. Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. J. Natl. Cancer. Inst. 95(3):2003;198-205.
5. Esteller M., Garcia A., Martinez-Palones J.M., Xercavins J., Reventos J. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis. 18(12):1997;2307-2311.
6. Tonetti C., Amiel J., Munnich A., Zittoun J. Impact of new mutations in the methylenetetrahydrofolate reductase gene assessed on biochemical phenotypes: a familial study. J. Inherit. Metab. Dis. 24(8):2001;833-842.
7. Campos B., Diez O., Cortes J., Domenech M., Pericay C., Alonso C.et al. Conditions for single-strand conformation polymorphism (SSCP) analysis of BRCA1 gene using an automated electrophoresis unit. Clin. Chem. Lab. Med. 39(5):2001;401-404.
8. Pogue R., West S., Bushby K. Multiplex SSCP and heteroduplex analysis with Southern hybridization for large-scale mutation detection. Genomics. 54(1):1998;1-4.
9. Zuntar I., Topic E., Vukosavic D., Vukovic V., Demarin V., Begonja A.et al. Croatian population data for the C677T polymorphism in methylenetetrahydrofolate reductase: frequencies in healthy and atherosclerotic study groups. Clin. Chim. Acta. 335(1-2):2003;95-100.
10. Ronaghi M., Uhlen M., Nyren P. A sequencing method based on real-time pyrophosphate. Science. 281(5375):1998;363-365.
11. Lazarus R., Klimecki W.T., Palmer L.J., Kwiatkowski D.J., Silverman E.K., Brown A.et al. Single-nucleotide polymorphisms in the interleukin-10 gene: differences in frequencies, linkage disequilibrium patterns, and haplotypes in three United States ethnic groups. Genomics. 80(2):2002;223-228.
12. Martinez A., Pascual M., Pascual-Salcedo D., Balsa A., Martin J., de la Concha E.G. Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immun. 4(2):2003;117-121.
13. Pascual M., Nieto A., Mataran L., Balsa A., Pascual-Salcedo D., Martin J. IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun. 1(5):2000;338-340.
14. Jee S.H., Chiu H.C., Tsai T.F., Tsai W.L., Liao Y.H., Chu C.Y.et al. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells. J. Invest. Dermatol. 119(5):2002;1121-1127.
15. Cavet J., Dickinson A.M., Norden J., Taylor P.R., Jackson G.H., Middleton P.G. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood. 98(5):2001;1594-1600.
16. Ota N., Nakajima T., Nakazawa I., Suzuki T., Hosoi T., Orimo H.et al. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J. Hum. Genet. 46(5):2001;267-272.
17. Georges J.L., Loukaci V., Poirier O., Evans A., Luc G., Arveiler D.et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J. Mol. Med. 79(5-6):2001;300-305.
18. Villuendas G., San Millan J.L., Sancho J., Escobar-Morreale H.F. The -597 G→A and -174 G→C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. J. Clin. Endocrinol. Metab. 87(3):2002;1134-1141.
19. Loughlin J., Dowling B., Mustafa Z., Chapman K. Association of the interleukin-1 gene cluster on chromosome 2q13 with knee osteoarthritis. Arthritis Rheum. 46(6):2002;1519-1527.
20. Tseng L.H., Chen P.J., Lin M.T., Shau W.Y., Chaung S.M., Martin P.J.et al. Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese. Tissue Antigens. 57(4):2001;318-324.